InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Results of Meeting 19 Oct 2021 11:12AM $1.275 $0.013 fallen by 98.98%
$18 Opthea Corporate Presentation - October 2021 19 Oct 2021 9:24AM $1.270 $0.013 fallen by 98.98%
$18 Opthea Chairman's Address to the 2021 Annual General Meeting 19 Oct 2021 9:22AM $1.270 $0.013 fallen by 98.98%
$18 Ceasing to be a substantial holder 11 Oct 2021 7:13PM $1.285 $0.013 fallen by 98.99%
$18 Opthea's Phase 3 open for patient recruitment in Europe 5 Oct 2021 8:23AM $1.350 $0.013 fallen by 99.04%
$18 Change in substantial holding 1 Oct 2021 5:16PM $1.355 $0.013 fallen by 99.04%
$18 Ceasing to be a substantial holder 24 Sep 2021 8:15AM $1.350 $0.013 fallen by 99.04%
$18 Becoming a substantial holder 21 Sep 2021 7:23PM $1.245 $0.013 fallen by 98.96%
$18 Addendum to Notice of Meeting 21 Sep 2021 8:19AM $1.275 $0.013 fallen by 98.98%
$18 Ceasing to be a substantial holder 16 Sep 2021 8:23AM $1.350 $0.013 fallen by 99.04%
$18 Notice of Annual General Meeting and Proxy Form 14 Sep 2021 8:17AM $1.360 $0.013 fallen by 99.04%
$18 Opthea Appendix 4G Corporate Governance Statement amended 6 Sep 2021 12:22PM $1.390 $0.013 fallen by 99.06%
$18 Opthea to present at September Investor Conferences 3 Sep 2021 8:22AM $1.315 $0.013 fallen by 99.01%
$18 Opthea Appendix 4G Corporate Governance Statement 30 Aug 2021 8:22AM $1.420 $0.013 fallen by 99.08%
$18 Opthea reports Fiscal Year 2021 Results and Highlights 30 Aug 2021 8:21AM $1.420 $0.013 fallen by 99.08%
$18 Opthea Appendix 4E and Annual Report 30 Aug 2021 8:21AM $1.420 $0.013 fallen by 99.08%
$18 Becoming a substantial holder 27 Aug 2021 8:02AM $1.460 $0.013 fallen by 99.11%
$18 Becoming a substantial holder 25 Aug 2021 6:59PM $1.410 $0.013 fallen by 99.08%
$18 Ceasing to be a substantial holder 25 Aug 2021 6:18PM $1.410 $0.013 fallen by 99.08%
$18 Ceasing to be a substantial holder 24 Aug 2021 7:05PM $1.400 $0.013 fallen by 99.07%
$18 Becoming a substantial holder 24 Aug 2021 8:03AM $1.305 $0.013 fallen by 99%
$18 Ceasing to be a substantial holder 19 Aug 2021 8:10AM $1.250 $0.013 fallen by 98.96%
$18 Becoming a substantial holder 12 Aug 2021 8:13AM $1.250 $0.013 fallen by 98.96%
$18 Opthea to present at H.C Wainwright Ophthalmology Conference 11 Aug 2021 8:17AM $1.240 $0.013 fallen by 98.95%
$18 Opthea expands Phase 3 for OPT-302 into Canada 10 Aug 2021 8:16AM $1.240 $0.013 fallen by 98.95%

401 - 425 of 733 results

Page 17 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.